Differential Cardiovascular Outcomes of Each Antihypertensive Drug Class in Patients With Hypertension and Breast Cancer Undergoing Doxorubicin-Containing Chemotherapy

PURPOSE: The preemptive use of renin-angiotensin system (RAS) inhibitors may reduce doxorubicin (DOX)-related cardiotoxicity. Using the national insurance claims data of Korea, this study compared cardiovascular (CV) outcomes following the use of four major antihypertensive drug classes in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Hui-Jeong, Han, Sang-Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625866/
https://www.ncbi.nlm.nih.gov/pubmed/37704380
http://dx.doi.org/10.4048/jbc.2023.26.e34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625866/
https://www.ncbi.nlm.nih.gov/pubmed/37704380
http://dx.doi.org/10.4048/jbc.2023.26.e34

Ejemplares similares